Stability‐indicating ultra performance liquid chromatography method development and validation for simultaneous estimation of metformin, linagliptin, and empagliflozin in bulk and pharmaceutical dosage form

Stability Indicating LC Method Development for Hydroxychloroquine Sulfate Impurities as Available for Treatment of COVID-19 and Evaluation of Risk Assessment Prior to Method Validation by Quality by Design Approach

(2020) Thirupathi Dongala et al.   CHROMATOGRAPHIA

Stability‐indicating HPLC method for simultaneous quantification of 14 impurities in Excedrin tablet formulations and identification of new impurity by LC‐MS in accelerated stability studies.

(2019) Thirupathi Dongala et al.   BIOMEDICAL CHROMATOGRAPHY

Stability‐indicating RP‐HPLC method development and validation for determination of nine impurities in apixaban tablet dosage forms. Robustness study by quality by design approach

(2019) Velusamy B. Subramanian et al.   BIOMEDICAL CHROMATOGRAPHY

Stability-indicating LC method for the simultaneous determination of methyl paraben, propyl paraben, butylated hydroxytoluene and alpha-tocopherol contents in marijuana capsules

(2019) Thirupathi Dongala et al.   Journal of the Iranian Chemical Society

Mechanism of Metformin: A Tale of Two Sites

(2016) Ruisheng Song   DIABETES CARE

A Validated HPLC Method for the Determination of Linagliptin in Rat Plasma. Application to a Pharmacokinetic Study

(2016) Abeer Hanafy et al.   JOURNAL OF CHROMATOGRAPHIC SCIENCE

The Place of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Therapeutics: A “Me Too” or “the Special One” Antidiabetic Class?

(2015) Ricardo Godinho et al.   Journal of Diabetes Research